[{"data":1,"prerenderedAt":62},["ShallowReactive",2],{"q-nurse-112-2-medical-surgical-002":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":34,"lastmod":61},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":10,"stem":11,"options":12,"answer":17,"answerNote":18,"images":19,"explanation":20,"explanationDeep":21,"topics":22,"freq":25},"nurse-112-2-內外科護理學-002","nurse-112-2-medical-surgical-002",112,2,"有關重症肌無力病人之藥物使用護理指導，下列敘述何者正確？",{"A":13,"B":14,"C":15,"D":16},"鼓勵進食高蛋白食物，降低 prostigmin 的副作用","運動後服用 mestinon，避免肌肉無力","azathioprine 不可以與 prednisone 合併使用，會降低療效","若口服藥無效時，可以使用放射線 I 125 治療","A",null,[],"本題考點是重症肌無力(myasthenia gravis)病人的藥物使用護理指導。依疾病病生理,重症肌無力使用抗膽鹼酯酶藥物(如 prostigmin、mestinon)控制症狀,而高蛋白飲食有助改善營養與肌力並可緩和藥物相關的腸胃道副作用,故 A 正確。B 錯在 mestinon 應在活動或運動「前」約 30 分鐘服用,使藥效在肌肉需出力時達高峰,運動後才服為時已晚。C 錯在 azathioprine(免疫抑制劑)與 prednisone(類固醇)臨床上常合併使用以加強免疫調節,並非不可併用。D 錯在重症肌無力並無「放射線 I-125 治療」的處置,治療選項為抗膽鹼酯酶藥、免疫抑制、血漿置換、免疫球蛋白及胸腺切除,此敘述屬虛構。","重症肌無力是自體免疫攻擊神經肌肉接合處的乙醯膽鹼受體,導致易疲勞的肌肉無力。用藥依據:抗膽鹼酯酶藥(pyridostigmine\u002Fmestinon、neostigmine\u002Fprostigmin)抑制乙醯膽鹼分解,延長其在接合處作用而改善肌力,故須在需出力前服用。用藥兩大危象要辨別:肌無力危象(藥量不足,肌肉更無力)與膽鹼危象(藥物過量,出現流涎、腹瀉、瞳孔縮小等膽鹼過度徵象),鑑別可用 Tensilon(edrophonium)試驗。記憶點:抗膽鹼酯酶藥「餐前活動前先吃,讓力氣趕上需求」。",[23,26,29,32],{"term":24,"count":25},"重症肌無力",7,{"term":27,"count":28},"抗膽鹼酯酶藥物",3,{"term":30,"count":31},"mestinon 給藥時機",1,{"term":33,"count":31},"免疫抑制治療",[35,38,42,47,52,57],{"webId":36,"stem":37,"number":28,"year":9,"session":10},"nurse-112-2-medical-surgical-003","有關糖尿病病人運動之護理指導，下列何者正確？①運動可降低細胞對胰島素的敏感性而降低血糖 ②運動最好在飯後 1～2 小時做 ③運動型態建議使用大肌肉群的有氧運動 ④切勿注射完胰島素後立刻運動，以免發生高血糖現象",{"webId":39,"stem":40,"number":41,"year":9,"session":28},"nurse-112-3-medical-surgical-019","有關 Dopamine 作用的敘述，下列何者正確？①2 μg\u002Fkg\u002Fmin 會增加心肌的自動性，因此可減少心室節律障礙 ②可治療低血容量性休克 ③5～10 μg\u002Fkg\u002Fmin 主要作用是增加腎血流量 ④大於10 μg\u002Fkg\u002Fmin 作用是末梢血管收縮",19,{"webId":43,"stem":44,"number":45,"year":46,"session":10},"nurse-113-2-medical-surgical-013","病人接受白內障囊外摘除術後之護理指導，下列何者最適當？ ①用力咳嗽 ②彎腰洗頭 ③預防便秘 ④避免提重物",13,113,{"webId":48,"stem":49,"number":50,"year":51,"session":28},"nurse-114-3-medical-surgical-011","有關全髖關節置換術病人之術後護理措施，下列敘述何者最不適當？",11,114,{"webId":53,"stem":54,"number":55,"year":56,"session":31},"nurse-106-1-medical-surgical-065","有關 BUN 與 Serum Creatinine 比值的敘述，下列何者正確？",65,106,{"webId":58,"stem":59,"number":41,"year":60,"session":10},"nurse-107-2-medical-surgical-019","有關軟組織損傷病人的護理評估結果，下列何者顯示可能有腔隙症候群？",107,"2026-09-04",1788510747278]